Loading...
•
Dec 31, 2019
Vanda Q4 2019 Earnings Report
Vanda reported a revenue increase of 15% compared to Q4 2018, with net income at $4.2 million.
Key Takeaways
Vanda Pharmaceuticals Inc. announced its Q4 and full year 2019 financial results, with Q4 total revenues reaching $60.9 million, a 15% increase compared to the same period in 2018. The company reported a net income of $4.2 million for the quarter.
Total revenues for Q4 2019 were $60.9 million, a 15% increase year-over-year.
HETLIOZ® net product sales reached $38.6 million in Q4 2019, a 19% increase year-over-year.
Fanapt® net product sales were $22.3 million in Q4 2019, an 8% increase year-over-year.
Net income for Q4 2019 was $4.2 million.
Revenue by Segment
Forward Guidance
Vanda expects full year 2020 total revenues to be between $240 million and $260 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...